Details
Title
Detection of minimal residual disease by next generation sequencing in AL amyloidosis
Author
Sarosiek Shayna 1
; Varga, Cindy 2 ; Jacob, Allison 3 ; Fulciniti, Maria Teresa 4
; Munshi Nikhil 4
; Sanchorawala Vaishali 1
1 Boston Medical Center, Section of Hematology & Medical Oncology, Boston, USA (GRID:grid.239424.a) (ISNI:0000 0001 2183 6745); Boston University School of Medicine and Boston Medical Center, Amyloidosis Center, Boston, USA (GRID:grid.189504.1) (ISNI:0000 0004 1936 7558)
2 Tufts Medical Center, The John C Davis Myeloma and Amyloid Program, Boston, USA (GRID:grid.67033.31) (ISNI:0000 0000 8934 4045); Tufts Medical Center, Division of Hematology-Oncology, Boston, USA (GRID:grid.67033.31) (ISNI:0000 0000 8934 4045)
3 Adaptive Biotechnologies, Seattle, USA (GRID:grid.421940.a)
4 Dana-Farber Cancer Institute, Division of Hematologic Malignancies, Boston, USA (GRID:grid.65499.37) (ISNI:0000 0001 2106 9910)
; Varga, Cindy 2 ; Jacob, Allison 3 ; Fulciniti, Maria Teresa 4
; Munshi Nikhil 4
; Sanchorawala Vaishali 1
1 Boston Medical Center, Section of Hematology & Medical Oncology, Boston, USA (GRID:grid.239424.a) (ISNI:0000 0001 2183 6745); Boston University School of Medicine and Boston Medical Center, Amyloidosis Center, Boston, USA (GRID:grid.189504.1) (ISNI:0000 0004 1936 7558)
2 Tufts Medical Center, The John C Davis Myeloma and Amyloid Program, Boston, USA (GRID:grid.67033.31) (ISNI:0000 0000 8934 4045); Tufts Medical Center, Division of Hematology-Oncology, Boston, USA (GRID:grid.67033.31) (ISNI:0000 0000 8934 4045)
3 Adaptive Biotechnologies, Seattle, USA (GRID:grid.421940.a)
4 Dana-Farber Cancer Institute, Division of Hematologic Malignancies, Boston, USA (GRID:grid.65499.37) (ISNI:0000 0001 2106 9910)
Publication year
2021
Publication date
Jun 2021
e-ISSN
20445385
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2543576765
Copyright
© The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.